Britain authorizes Merck’s molnupiravir, the world’s first approval of oral covid-19 treatment pill

Posted on AllSides November 4th, 2021
From The Left
Merck & Co./AP

Regulators in Britain granted approval to the experimental drug molnupiravir from U.S. pharmaceutical giant Merck on Thursday, marking the first authorization from a public health body for an oral antiviral treatment for covid-19 in adults.

Experts have said that if widely authorized, the medicine could have huge potential to help fight the coronavirus pandemic: Pills are easier to take, manufacture and store, making them particularly useful in lower- to middle-income countries with weaker infrastructure and limited vaccine supplies.

“We will continue to move with both rigor and urgency to bring...

Read full story
Some content from this outlet may be limited or behind a paywall.

Washington Post

AllSides Media Bias Rating: Lean Left
AllSides Media Bias Rating: Lean Left
106712/84319
See full bias rating for Washington Post
Learn about media bias
https://www.washingtonpost.com/health/2021/11/04/covid19-pill-merck-molnupiravir-approval-uk/

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right